Generic GLP-1 launch in US: Q3 2026
63%YES chance
Yes
63%
No
37%
Now 63.0%
Resolution
Resolves to the quarter the first FDA-approved generic GLP-1 (semaglutide or tirzepatide) launches in the US.
Source: https://www.fda.gov/
Resolves by May 23, 2027.
Recent trades
- YES@haydenlopez58.3 sh@ 53%30 SP
- NO@skylerunderhill47.3 sh@ 63%17 SP
- NO@finleyyoon113.7 sh@ 65%37 SP
- NO@lanejensen58.3 sh@ 70%17 SP
- NO@frankieblake306.6 sh@ 72%71 SP
- YES@alexalvarez52.2 sh@ 81%42 SP
- YES@taylorvargas20.1 sh@ 80%16 SP
- YES@kaiunderhill102.8 sh@ 79%80 SP
- YES@rowancarrillo51.6 sh@ 76%39 SP
- YES@lanejensen109.9 sh@ 75%80 SP
- YES@caseyokafor109.2 sh@ 71%75 SP
- YES@kaipatel70.8 sh@ 66%46 SP
- YES@parkerokafor111.8 sh@ 63%68 SP
- NO@skylerunderhill148.8 sh@ 58%57 SP
- YES@frankieblake64.4 sh@ 65%41 SP
- YES@skylerpowell91.6 sh@ 62%55 SP
- YES@drewhayes53 sh@ 58%30 SP
- YES@morgansantos48.1 sh@ 55%26 SP
Top holders
YES holders
No holders yet.
NO holders
No holders yet.
News
Refreshed every 6 hours
No news yet. Endcap's news crawler refreshes every 6 hours.
Discussion
- @rowanmonroeRowan Monroe7 days ago
interesting angle.